Pfizer Inc., said the Securities and Exchange Commission has requested documents about its Cox-2 class of painkillers.
In its quarterly filing submitted to the regulator this week, the company didn't say when the SEC made its request. Pfizer earlier received a similar request from the U.S. Justice Department.
